Multidisciplinary Approaches to Cancer Symposium
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States. A total of 1,658,370 new cancer cases and 589,430 cancer deaths are projected to occur in the United States in 2015. Because they are so diverse in their individual biology, clinical course management of many of these cancers is increasingly difficult, constantly evolving and fraught with controversy. In this environment it has become much more difficult and complicated for those involved in the care the cancer patient to remain current in best practice for each of the many tumor types that constitute “CANCER”. This year our faculty will profile and discuss the clinical and technical advances, promising clinical trials data, national guidelines, and key controversies in the management of breast cancer, lung cancer, cns tumors, gastrointestinal malignancies, melanoma, genitourinary malignancies, head and neck cancer, gynecologic cancer and hematologic malignancies. Through cutting edge lectures, case discussion, and interactive question and answer sessions this intensive 4-day program will provide participants with an enhanced ability to interpret and apply these best treatment options into their individual cancer practices.
EVENT DETAILS AND REGISTRATION
Date:November 04, 2015
Time: 04:00 PM - 04:00 PM (PT)
Location:Wynn Encore, 3131 South Las Vegas Blvd., Las Vegas, NV 89109
Agenda:TOPICS COVERED INCLUDE:
- Breast cancer
- Lung cancer
- Head and neck cancers
- Genitourinary and gastrointestinal cancers
- Gynecologic cancer
- CNS tumor
- Complementary and alternative medicine
- Implement current best practices for diagnosis, classification and detection of prognostic and therapeutic markers. Cite the advances and controversies in breast cancer management as they relate to treatment and reconstruction
- Identify the optimal techniques in screening, radiation and therapy for patients with gynecological and urologic malignancies
- Integrate genetic counseling into the management of patients at risk for gynecologic cancer
- Assess how new data and therapeutic techniques can be incorporated in the individualized treatment of patients with pancreatic cancer, rectal cancer and liver metastases
- Describe the current status and new developments in the treatment of the patient with melanoma
- And much more ...
Who should attend:This educational program is directed towards internists, family practitioners, gynecologists, surgeons, medical, surgical and radiation oncologists, hematologist, urologists, dermatologists and other allied health care professionals interested in the treatment of patients with cancer.
CME credits:ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 20 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The following credit type(s) are being offered for this course:
- AMA PRA Category1™ (20.25)
- American Board of Surgery - Maintenance of Certification (20)
- Registered Nurses: Nurses may report up to 20 credit hour(s) toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). CME may be noted on the license renewal application in lieu of a BRN provider number.
- Physician's Assistants: The National Commission on CertTM